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Summary 1 
Background  2 
Until recently members of the Cronobacter genus (formerly known as Enterobacter sakazakii) were a 3 
relatively unknown cause of hospital infections. However their association with infant infections and in 4 
particular through the consumption of contaminated reconstituted infant formula in neonatal intensive 5 
care units, has resulted in international efforts to improve neonatal healthcare. 6 
 7 
Aim 8 
This review considers the current status of our understanding of this emergent group of bacterial 9 
pathogens and the steps taken to reduce neonatal infection.  10 
 11 
Methods 12 
A literature review was undertaken to collate our current knowledge of the Cronobacter genus, with 13 
respect to recent taxonomic revisions, sources and clinical relevance.  14 
 15 
Findings 16 
The majority of severe neonatal meningitis infections are associated with only one of the ten 17 
Cronobacter species, and in particular the clonal complex known as C. sakazakii ST4.  International 18 
efforts by FAO-WHO to reduce the risk of neonatal infection by this organism have resulted in 19 
improved microbiological safety of powdered infant formula (PIF) and revised guidelines for feeding 20 
practices have been problematic.  However the majority of infections are in the adult population, the 21 
sources of which are unknown. 22 
 23 
Conclusion 24 
International improvements in the microbiological safety of PIF and advice on feeding practices have 25 
been directed towards improving neonatal healthcare following the heightened awareness of 26 
Cronobacter infections in this particular age group. While these are likely to also reduce neonatal 27 
exposure to other opportunistic bacterial pathogens, nevertheless a number of unresolved issues 28 
remain with respect to the practicalities of feeding premature neonates safety while following WHO 29 
advice.30 
 3
General Introduction 1 
This review concerns the bacterial genus Cronobacter which can cause severe illness in the highly 2 
vulnerable neonates, infants and the elderly.  The organism has come to prominence due to its 3 
association with severe though rare neonatal infections leading to necrotizing enterocolitis, 4 
septicaemia and meningitis, which can be fatal. As neonates are frequently fed reconstituted 5 
powdered infant formula (PIF), which is not a sterile product, this potential vector has been the focus 6 
of attention for reducing infection risk to neonates as the number of exposure routes is limited.  7 
Meanwhile, the majority of Cronobacter infections occur in the adult population but are less severe. 8 
Cases of Cronobacter infection in all age groups are probably under-reported for a number of reasons 9 
such as misidentification as Enterobacter cloacae.1 Fortunately our understanding of Cronobacter has 10 
grown considerably in recent years.  In part this is due to new developments and applications in 11 
clinical microbiology of Next Generation Sequencing methods, which have led to rapid improvements 12 
in our understanding of this organism; changing our perspective of the former Enterobacter sakazakii 13 
species into a genus composed of 10 species, with high clonality and host-adaption, along with 14 
improved methods of identification and typing.  This review aims to bring together our current 15 
knowledge on the clinical aspects of Cronobacter, and consider unresolved issues concerning the 16 
hygienic preparation of powdered infant formula. 17 
 18 
Cronobacter taxonomy and phylogeny: 19 
The bacterial genus Cronobacter was formerly known as Enterobacter sakazakii, and was first defined 20 
as a new genus in 2007.2 It is a member of the Enterobacteriaceae family and is closely related to the 21 
Enterobacter and Citrobacter genera.  In recent years the Cronobacter genus has undergone a 22 
number of revisions and currently contains 10 species.3,4  The formally recognised species are C. 23 
sakazakii, C. malonaticus, C. universalis, C. turicensis, C. muytjensii, C. dublinensis, C. condimenti, C. 24 
helveticus, C. pulveris and C. zurichensis; Figure 1.  These include the former bacterial species 25 
Enterobacter sakazakii, E. helveticus, E. pulveris and E. turicensis. Subsequently it is uncertain which 26 
specific Cronobacter species were referred to in many pre-2007 publications.  The species can be 27 
grouped, with the mostly clinically relevant being Group1: C. sakazakii and C. malonaticus which form 28 
the majority of clinical isolates, and Group 2: C. turicensis and C. universalis which have been less 29 
frequently reported. The close relatedness of these species is shown in Figure 1.  The other species 30 
are primarily environmental commensals and are probably of little clinical significance. According to 31 
phylogenetic analysis these major divisions formed about 41 million years ago and further host-32 
adaptation has occurred as will be considered later with the specific case of C. sakazakii sequence 33 
type 4.5 34 
 35 
Cronobacter physiology 36 
Cronobacter spp. can grow over a wide temperature range.  The lowest being near refrigeration 37 
temperatures (~5oC), the optimal ~37-39oC, with the maximum growth temperature is 44-47oC.6 The 38 
organism’s tolerance to desiccation is well recognised.  It can survive for two years desiccated in 39 
infant formula and then rapidly grow on reconstitution.7 The organism often produces a capsule which 40 
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can be so copious that on milk agar plates the colonies drip onto the lid of inverted Petri dishes.8 1 
Cronobacter spp. are able to adhere to silicon, latex and polycarbonate, stainless steel, glass and 2 
polyvinyl chloride.6,9  These materials are commonly used for infant-feeding and food preparation 3 
equipment and, if contaminated, may increase the risk of infection.  This capsular material may 4 
facilitate the organism forming biofilms that are resistant to cleaning and disinfectant agents.10 The 5 
organism has been isolated as part of the mixed flora biofilm in enteral feeding tubes of neonates.11  6 
 7 
Virulence traits  8 
The Cronobacter are opportunistic pathogens though few virulence factors have been identified to 9 
date. Some strains can invade human intestinal cells, replicate in macrophages, and invade the blood 10 
brain barrier.12 Based on the analysis of archived strains and clinical outcome of the 1994 outbreak in 11 
France, it was proposed that certain strains of C. sakazakii were more virulent, and this has been 12 
confirmed by multilocus sequence typing (MLST).13,14  The route of infection is probably through 13 
attachment and invasion of the intestinal cells, and therefore genes encoding surface appendages 14 
such as pili (fimbriae) have been studied. A number of fimbriae clusters were identified in the genomes 15 
of Cronobacter species.1,15-17 Many are common to all species, though there are some interesting 16 
variations. C. sakazakii is the only Cronobacter species encoding for β-fimbriae, whereas the 17 
genomes of the other species encode for curli fimbriae.1,16 This may reflect evolution to the host 18 
ecosystem.   19 
Since Cronobacter is associated with neonates and infants, the utilization of iron from breast 20 
milk and formula could be an important virulence trait.  A number of iron assimilation mechanisms 21 
have been found in Cronobacter species.1,15-18 Type VI secretion system (T6SS) is a newly described 22 
system that may be involved in adherence, cytotoxicity, host-cell invasion, growth inside macrophages 23 
and survival within the host. Five putative T6SS clusters have been identified Cronobacter spp. 24 
genomes.1,17-19 It remains to be determined whether they encode functional type VI secretion systems.  25 
Cronobacter produce an enterotoxin, and as with neonatal meningitic E. coli, the outer membrane 26 
proteins ompA and ompX possibly have roles in the organism penetrating the blood brain barrier.  The 27 
mechanism(s) leading to the destruction of the brain cells in unknown and could in part be a host 28 
response.  The organism also encodes for a number of haemolysins.1,19 29 
C. sakazakii is unique in the Cronobacter genus in its utilization of exogenous sialic acid, and 30 
this may have clinical significance. The ability to utilise sialic acid could be a major evolutionary host-31 
adaptation since the compound is found in breast milk, mucin and gangliosides.20 Sialic acid is also an 32 
ingredient in powdered infant formula due to its association with brain development. C. sakazakii is 33 
also able to grow on the ganglioside GM1 as a sole carbon source.20 34 
High levels of heat-stable lipopolysaccharide (LPS, also known as endotoxin) in infant formula 35 
enhances the translocation of Cronobacter across both the intestines and the blood–brain barrier, and 36 
therefore increase the risk of bacteraemia in neonates.23,24,25  Kim and Loessner speculated that 37 
frequent LPS contamination of PIF (known to disrupt tight junctions) might contribute to the 38 
invasiveness of Cronobacter across the blood-brain barrier.24 It is known that the levels of LPS in PIF 39 
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vary 500-fold.25 In addition, the oligopolysaccharide component of the  LPS layer can serve as a basis 1 
for serotyping and other characterisation methods.21,22   2 
Cronobacter spp. tend to be more sensitive to most antibiotics compared to other 3 
Enterobacteriaceae, though resistance to ampicillin has developed.  In 1980, all strains tested were 4 
susceptible to ampicillin, whereas in 2001 Lai described five cases of Cronobacter infection in which 5 
one or more of the isolates were resistant to ampicillin and most cephalosporins of 1st and 2nd 6 
generation.26,27 In 2001, Lai reported increasing β-lactamase production among Cronobacter strains.27 7 
Similarly, Block and colleagues reported that all Cronobacter isolates tested were β-lactamase 8 
positive.28 Caubilla-Barron et al. in a retrospective study of a NICU outbreak in 1994, reported two 9 
neonatal deaths from ESBL-encoding C. sakazakii strains.8 It is of interest that indistinguishable 10 
pulsetype strains were non-ESBL, indicating the possible acquisition of the ESBL genes from the 11 
individual neonatal intestinal flora during the infection period. 12 
 13 
Non-human sources of Cronobacter spp. 14 
Cronobacter spp. has been isolated from a range of foods including cheese, meats, milk powder, 15 
powdered infant formula, weaning foods, and a large portion of food ingredients; Table 1.29,30 Although 16 
the bacterium is isolated from many foods, no foodborne infections have not been reported.  A 17 
productive source of Cronobacter strains are fresh or dried herbs and spices with ~30% incidence29.   18 
Rats, flies and cockroaches may be additional sources of contamination.31,32,33  19 
The bacterium has been isolated from the home environment; household dust, vacuum 20 
cleaning bags and also from utensils used for the reconstitution of powdered infant formula; Table 1.34 21 
Hence contamination of reconstituted infant formula can be intrinsic or extrinsic in origin. The 22 
bacterium has also been isolated hospital environments, as well as various areas in milk powder and 23 
PIF processing plants; roof, shoes, and roller driers.35,36,37,38   24 
The organism has been recovered from previously unopened tins of powdered infant formula 25 
indicating intrinsic contamination; Table 1.39,40,41 Accurate enumeration is difficult but is generally in the 26 
order of <1 bacterial cells/100g. The intrinsic prevalence of Cronobacter in powdered infant formula 27 
has been determined a number of times and varies between 2-14%, with no published reports 28 
exceeding 1 cell/g.  Hence the consideration of opportunities for extrinsic bacterial contamination, and 29 
multiplication, especially temperature abuse following reconstitution as it would allow the bacterium to 30 
multiply and increase the risk of infection.  Currently microbiological criteria for Cronobacter spp. are 31 
required for infant formulas with an intended target age <6 months.42 A presence/absence test is 32 
applied to large volumes due to the low incidence of the organism in the product.  Although the 33 
organism has been recovered from follow up formulas (infant formulas with intended target age >6 34 
months) and weaning foods, there is currently insufficient epidemiological evidence to support the 35 
implementation of criteria for these products.   36 
A limited number of studies have shown that Cronobacter is waterborne.3,43,44  This important 37 
issue has not received as much attention as bacterial contamination of PIF. As will be considered 38 
later, since powdered infant formula is not a sterile product one method of reducing neonatal exposure 39 
to Cronobacter has been the recommendation to reconstitute with water >70°C to kill any vegetative 40 
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bacteria present.39,40,45 This advice has not been adopted by all countries. It should be noted that 1 
detailed microbiological examination of the USA December 2011 infant infection cases revealed the 2 
presence of C. sakazakii in the PIF reconstitution water which was a close match (differed by 35/3036 3 
nucleotides of the MLST alleles) to that recovered from the cerebral spinal fluid of the associated 4 
infant with meningitis.14   5 
 6 
Human and clinical sources of Cronobacter spp. 7 
Asymptomatic human carriage of Cronobacter spp. has been reported in a few studies with recovery 8 
from mouth, skin and faeces; Table 1.  9 
 Cronobacter spp. have been isolated from various hospital environmental and clinical 10 
samples; cerebrospinal fluid, blood, bone marrow, sputum, urine, inflamed appendix, breast abscess, 11 
and conjunctivae.3,5,8,13,16,27,46,47  Nazarowec-White and Farber studying three isolates obtained from 12 
one hospital over 11 years showed that they were indistinguishable.48 Smeets et al. showed that 13 
isolates from a contaminated dish brush used for cleaning bottles in a hospital and the isolates from 14 
three patients were identical making an epidemiological connection likely.49 The organism has also 15 
been isolated from a doctor’s stethoscope and from nursery food preparation equipment such as 16 
spoons and a blender.26,50,51,52 The organism has been found as part of the mixed flora biofilm in 17 
enteral feeding tubes of neonates not fed PIF.11   Related to this, laboratory studies have shown that 18 
one contaminated feed passing through the feeding tube would subsequently contaminate further 19 
feeds due to bacterial attachment to the inner tube wall and multiplication.53 20 
 21 
Isolation, identification and typing methods 22 
As the organism has only been reported at low numbers (<1cfu/g) in PIF, a large volume of material 23 
needs to be tested in microbiological analysis. Therefore presence/absence testing of bacteria in PIF 24 
is applied rather than direct enumeration.  This includes the use of chromogenic agars, along with 25 
DNA-based identification and fingerprinting techniques. Although it is generally possible to differentiate 26 
Cronobacter species by biochemical profiling, molecular methods are increasingly used as a more 27 
rapid and reliable tool to study bacterial genomic diversity and to track sources of infection.  Since the 28 
organism is ubiquitous, typing schemes are required both for epidemiological and environmental 29 
investigation.  For epidemiological analysis (ie. tracing source and dissemination during an outbreak), 30 
PFGE with two restriction enzymes (Xba1 and Spe1) is the most common method.8  The technique is 31 
widely employed and can be used for transnational investigations, as per PulseNet, since the gel 32 
results can be electronically analyzed (http://www.cdc.gov/pulsenet/). The method is limited however 33 
as not all strains can be typed, non-identical strains can give the same PFGE profile and the method 34 
does not give the relationship between strains.35,54   35 
On a larger scale, multilocus sequence typing (MLST) is increasingly being applied to understand 36 
the evolution and diversity of bacterial pathogens, for example E. coli ST131, MRSA-15 ST22 and 37 
Klebsiella pneumoniae ST258.55  The method defines sequence types (ST) based on 7 allelic profiles 38 
and clonal complexes based on relatedness of the sequence types (1-3 loci differences).  The MLST 39 
scheme for Cronobacter has been established and is available online with approximately 600 strains 40 
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profiles (www.pubMLST.org/cronobacter/).5,56,57  The site also includes open access for  the further 1 
analysis of all published Cronobacter genome sequences using the ‘Bacterial Isolate Genomes 2 
Sequence Database’ (BIGSdb) facility.58  The web site contains the MLST protocols, as well as >200 3 
DNA sequence defined profiles for strains which have been collected from various sources and 4 
countries over a 60 year period. The Cronobacter MLST analysis is based on 7 housekeeping genes; 5 
atpD, fusA, glnS, gltB, gyrB, infB and ppsA.  The 7 sequenced alleles can be concatenated together to 6 
give 3036 nucleotide sequence for phylogenetic analysis (Fig 1).  This analysis has revealed a 7 
remarkably strong clonal nature in the Cronobacter genus.5,57  These clones may reflect different 8 
ecologies of the organism.  The clonal complex C. sakazakii ST4 is a DNA sequence defined 9 
evolutionary lineage for the causative agent of neonatal meningitis among the Cronobacter 10 
isolates.5,13,14,57  This remarkable discovery gives a clear direction for further meningitis research with 11 
the bacterium. Neisseria meningitidis also shows clonality of meningitis infection. To date there does 12 
not appear to be such a clear link between sequence type and other Cronobacter infections, such as 13 
necrotizing enterocolitis.   14 
It should be noted that 16S rDNA sequence analysis of archived strains has revealed that the use 15 
of phenotyping in early studies led to a number of mis-identifications in the literature.16 These include: 16 
1. An independent fatal case of neonatal sepsis due to E. cloacae during a C. sakazakii outbreak 17 
in a neonatal intensive care unit.8 18 
2. Neonatal intensive care unit outbreak attributed to E. sakazakii, reidentified as E. 19 
hormaechei.59 20 
3. A reported quinolone-resistant E. sakazakii strain, reidentified as E. hormaechei.60 21 
4. E. sakazakii strain used for oligo-polysaccharide structure determination, re-identified as E. 22 
ludwiggi.61 23 
Such mis-identifications are likely to continue given that the database for a commonly used 24 
phenotyping based method does not recognised the 2007 taxonomic revision of Cronobacter and 25 
continues to use the old E. sakazakii nomenclature, and three of the most recently defined 26 
Cronobacter species (C. helveticus, C. pulveris and C. zurichensis) are not recognised even as E. 27 
sakazakii. 28 
 29 
Cronobacter spp. infections 30 
A number of Cronobacter infection incidents have been reported as outbreaks.8,39,40 In the USA, the 31 
reported Cronobacter infection incidence rate is 1 per 100 000 infants. This incidence rate increases to 32 
9.4 per 100 000 in infants of very low birth weight, i.e. <1.5 kg.40   Fatal Cronobacter infections of 33 
infants have followed cases of necrotising enterocolitis (NEC), septicaemia and meningitis.62,63  34 
Infections in older age groups are principally bacteraemia as well as urosepsis and wound infections. 35 
Infants can be colonized by more than one strain of Cronobacter, and therefore multiple isolates need 36 
to be characterized in epidemiological investigations.8   37 
NEC is non-invasive (as well as multifactorial), whereas in septicaemia and meningitis the 38 
organism has attached and invaded presumably through the intestinal epithelial layer. NEC is a 39 
common gastrointestinal illness in neonates and can be caused by a variety of bacterial pathogens.  It 40 
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is characterized by ischaemia, bacterial colonisation of the intestinal tract, and increased levels of 1 
proteins in the gastrointestinal lumen.   The incidence of NEC is 2-5% of premature infants and 13% in 2 
those weighing <1.5kg at birth.  It is 10 times more common in infants fed formula compared with 3 
those fed breast milk. NEC has a high mortality rate; 15-25% of cases. Cronobacter has been 4 
implicated as a causative agent of NEC, but its role in the pathogenesis of the disease is somewhat 5 
unclear.  There are reports of Cronobacter isolation from babies who developed NEC and these 6 
strains were indistinguishable by PFGE from those isolated from meningitis cases.8 This suggests that 7 
there is an association between Cronobacter occurrence and NEC, although until recently, the 8 
organism has not been conclusively proven to cause the disease.  9 
Cronobacter-related meningitis is characterized by a mortality rate of 40-80 % and generally a 10 
very poor clinical outcome.  The bacterium causes cystic changes, abscesses, fluid collection, brain 11 
infarctions, hydrocephalus, necrosis of brain tissue and liquefaction of white cerebral matter. This 12 
pathogenesis is different to that caused by both Neisseria meningitidis and neonatal meningitic E. coli.  13 
Some reports suggest a similarity between the tropism of Cronobacter and the closely related 14 
organism Citrobacter koseri for invasion and infection of the central nervous system. Patients surviving 15 
Cronobacter-related meningitis often suffer from severe neurological sequelae, such as 16 
hydrocephalus, quadriplegia and retarded neural development.16,62,63 The infection usually arises 17 
between the fourth and fifth day after birth and it can be fatal within hours to days following the first 18 
clinical signs. Compared with patients suffering from Cronobacter-induced enterocolitis, infants in 19 
whom meningitis developed tend to have normal gestational age and birth weight.   20 
In December 2011, there was considerable publicity concerning neonatal Cronobacter infections in the 21 
United States.64 All but one isolate from the meningitic cases were in the C. sakazakii ST4 clonal 22 
complex.14 23 
Infections caused by Cronobacter in adults comprise a wide range of symptoms from 24 
conjunctivitis, biliary sepsis, urosepsis and appendicitis to wound infection and pneumonia. Adult 25 
patients at increased risk include those previously treated with antibiotics, immuno-compromised and 26 
elderly patients, those with medical implants or with acute, chronic, or serious illnesses. C. sakazakii 27 
can cause urinary tract infections, though to date this aspect has not been studied in any detail. The 28 
only published age-profiled data is for 819 Cronobacter spp. bacteraemia cases reported for England 29 
and Wales between 1992 and 2007.41 In this report, the majority (91%) of bacteraemia cases were 30 
patients >15 years in age.  31 
 32 
Sources of infection 33 
While the source of contamination in Cronobacter-related outbreaks has not always been confirmed, 34 
breast milk substitutes (one group of PIF products) have been epidemiologically or microbiologically 35 
established as the source of infection in a number of cases.8,39,40,41  Although an outbreak in a NICU in 36 
Tennessee in 2001 is often cited as a strong link between the presence of Cronobacter in powdered 37 
infant formula and Cronobacter infection, it is overlooked that the formula fed to the infant in 38 
Tennessee was in fact a non-infant formula and was not intended to be consumed by neonates.65   39 
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As already covered, the C. sakazakii clonal complex ST4 is strongly associated with cases of 1 
meningitis and it is notable that this clonal complex has been reported to be frequently isolated from 2 
milk powder factories, powdered infant formula (PIF) processing plants and from PIF in Ireland, 3 
Switzerland, Germany and Australia.36,37,38  Sonbol et al. reported that 24% of strains isolates from the 4 
environment of 6 milk powder manufacturing plants in Australia and Germany were C. sakazakii 5 
ST4.38 6 
Infections which have been directly linked to reconstituted PIF may have been the result of 7 
intrinsic or extrinsic contamination during preparation and administration.  A common feature in some 8 
of these outbreaks is the opportunity for temperature abuse of the prepared feed, which would permit 9 
bacterial growth.  In reported outbreaks in France and USA, the neonates were fed using perfusion 10 
devices where the reconstituted PIF is slowly pumped over several hours at ambient temperature into 11 
the neonate’s stomach through an enteral feeding tube.8,65 Using this procedure there is the possibility 12 
of bacterial multiplication in the syringe leading to the ingestion of large numbers of Cronobacter by 13 
the neonate.   14 
The neonate has an immature immune system and a low intestinal microflora density.  15 
Consequently, if a large number of Cronobacter cells were ingested they would not be outcompeted 16 
by the resident intestinal flora.  Following invasion of the intestinal cells, the lack of a developed 17 
immune system could make the neonate more prone to systemic infection.  No infectious dose has 18 
been determined for neonates.   Animal studies by Pagotto and others have used large numbers of 19 
Cronobacter cells (~108) for infection studies.66  Whether this number is reflective of that necessary for 20 
neonate infection is uncertain, but it does contrast with the number of cells reported in contaminated 21 
PIF (<1 cfu/g), and may therefore indicate the significant role of temperature abuse in enabling 22 
bacterial multiplication. 23 
It is pertinent to note that Cronobacter sakazakii has been isolated from the tracheae, and 24 
sputum as well as from the feeding tubes of neonates fed breast milk and ready-to-feed formula, not 25 
infant formula; Table 1.8,11,67  Therefore wider sources of the organism during an outbreak need to be 26 
investigated, not just the use of PIF.  The 1994 NICU outbreak in France showed that infants can be 27 
colonized by more than one strain of Cronobacter, and therefore multiple isolates need to be 28 
genotyped in epidemiological investigations to increase the chance of tracing probable source.8 29 
Bowen and Bradden reported that there are a number of neonatal cases which have no links 30 
with the ingestion of reconstituted infant formula.63 Pertinent to this, is the recognition of bacterial 31 
colonisation of the nasogastric enteral feeding tube, and the isolation of C. sakazakii from tubes from 32 
neonates feed breast milk, and (sterile) ready to feed formula.   Breast milk can contain the bacterium, 33 
and the C. malonaticus type strain (LMG 23826T) was isolated from a breast abscess.  In some 34 
countries breast milk from mothers with mastitis is still fed to the neonate. Breast milk has been a 35 
suspect source in two meningitis cases.68,69 Cronobacter infections of babies with breast milk as sole 36 
source of feed have been reported in US and Israel; Block pers. comm.28,70  37 
Cronobacter species have also been isolated from hospital air, dust, human intestines and 38 
throats.  Hence control of microbiological content of PIF will not necessarily totally remove the risk of 39 
neonate infection by this bacterium.   40 
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 1 
Consequences and current issues. 2 
To date the raised awareness of the organism has focussed on infant infections and resulted in 3 
changes in the microbiological criteria for PIF and reconstitution procedures.39,40,41,42  Those identified 4 
as being at high risk of Cronobacter infection are neonates (especially low birth weight) for whom their 5 
source of nutrition will be limited to breast milk, fortified breast milk, or breast milk replacement.  6 
Hygienic preparation of feed is essential due to their immature immune system and lack of competing 7 
intestinal flora. Key advice from these FAO-WHO  risk assessments was that PIF should be 8 
reconstituted with water >70°C, minimise any storage time by not preparing in advance and if storage 9 
for short periods is necessary then the temperature should be <5°C. The high water temperature will 10 
drastically reduce the number of vegetative bacteria present, and minimising the storage period will 11 
reduce the multiplication of any surviving organisms.  These recommendations have been well 12 
addressed by the WHO ‘Guidelines for the safe preparation, storage and handling of powdered infant 13 
formula’.42   However this has subsequently caused a number of additional issues for weaning foods, 14 
follow-on formulas, fortified breast milk, and probiotic-supplemented PIFs as consider below. 15 
As referred to above, the WHO guidelines for hygienic preparation of PIF are aimed at reducing 16 
the number of bacteria in the reconstituted product by using hot water and limiting the time available 17 
for any survivors to multiply.42  However a wider perspective is that neonates are frequently feed via 18 
enteral feeding tubes.  These tubes are in place for prolonged periods (even several days) to reduce 19 
distress to the neonate by the gagging reaction.  However Cronobacter, and other opportunistic 20 
pathogens can attach and colonise these tubes which are at 37°C, and at regular intervals receive 21 
fresh feed.11 This scenario is applicable to all neonates with nasogastric tubes, and not only those on 22 
reconstituted PIF.  In fact Cronobacter and other Enterobacteriaceae have been isolated from such 23 
tubes in intensive care units from neonates receiving breast milk and various other feeding regimes at 24 
levels up to 107 cfu per tube.11 Therefore hygienic practices and avoidance of temperature abuse are 25 
vitally important regardless of the type of feed. 26 
 27 
So where are we now?  28 
1. Ironically despite the international changes, the original Tennessee outbreak which 29 
precipitated the FAO-WHO risk assessments and WHO preparation of PIF guidelines could 30 
still occur. Why? Because the outbreak was due to the use of formula that was not intended 31 
for consumption by infants, therefore the product is currently not subject to the revised 32 
microbiological criteria. 33 
2. The FAO-WHO recommended reconstitution of powdered infant formula with water >70°C is 34 
not followed in all countries such as the US, although it is supported by the CDC. Dipping a 35 
thermometer into reconstituted formula would have its own inherent problems of 36 
contamination and so the advice has been to use water which has been boiled in a kettle and 37 
left to cool for 30 minutes.  Aside from the variation in cooling curves according to volume of 38 
water and type of kettle, this is impractical for premature babies who require only small 39 
volumes of formula, and are fed at 2 hourly intervals. This practice may result in staff being 40 
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taken away from bedside care to oversee feed preparation.  The term ‘powdered infant 1 
formula’ includes ‘breast milk fortifiers’.  These products are added to supplement the 2 
nutritional value of mother’s milk.  They are not reconstituted with water and cannot receive 3 
the heat-treatment to kill intrinsic bacteria. The use of high-temperature for reconstitution 4 
precludes the inclusion of probiotic bacterial cultures (such as Lactobacillus fermentum and L. 5 
reuteri) in PIFs, as marketed in some countries.  6 
3. Most Cronobacter infections are in adults, possibly primarily due C. malonaticus.5,16  The 7 
source of infection maybe through ingestion as the organism is ubiquitous in food, however it 8 
is also plausible that it is nasopharyngeal (like Neisseria meningitis) which could explain the 9 
cases of pneumonia and isolation from sputum. 10 
4. The source of C. sakazakii ST4 is of considerable interest since controlling this lineage could 11 
reduce neonatal exposure to severe, life-threatening infections. An informed assessment of 12 
neonatal exposure warrants further investigation for the prevalence of Cronobacter spp., 13 
especially ST4, in hospitals, PIF and other sources such as human carriage.47  14 
 15 
Late onset Gram negative bacterial sepsis remains a significant cause of neonatal morbidity/mortality 16 
and infections on NICUs are predominantly due to Enterobacteriaceae, whereas non-fermenting 17 
bacteria  (ie. Pseudomonas spp.) predominate in other ICU outbreaks.71,72 A recent UK neonatal unit 18 
outbreak has lead to development of specific national guidelines (under consultation) on the 19 
prevention and management of Gram negative sepsis in neonates.73 The incidence of sepsis in 20 
premature babies in England is 8/100 live births, and 71/1000 neonatal admissions.74  It should be 21 
noted that Cronobacter spp. are not the only Enterobacteriaceae isolated from PIF, and that the FAO-22 
WHO recommended that research should be undertaken into the other Enterobacteriaceae and 23 
Acinetobacter spp. in PIF.39,40 These organisms were termed ‘Category B; plausible causing 24 
infections, but without supporting epidemiological evidence’ by the expert committees, whereas 25 
Cronobacter spp. and Salmonella serovars were ‘Category A: Clear evidence of causality’. A wide 26 
range of Enterobacteriaceae can be present in PIF, and are the same species as occur in neonatal 27 
infections. However cases linking isolates from infants and PIF have not be substantiated.8,59,75 28 
 29 
Therefore, despite considerable improvement in our understanding of the emergent bacterial pathogen 30 
now known as Cronobacter, there remains a number of practical issues concerning the hygiene 31 
feeding of neonates, and the possible significance in adult infections which are not studied to date. 32 
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